Global Market for Autoimmune Monoclonal Antibodies growing at a CAGR of 7.84%
According to the report “Autoimmune Monoclonal Antibodies Market”, published by Market Data Forecast, the global market is projected to reach USD 25,274.7 million by 2021, at a CAGR of 7.84% from 2016 to 2021.View Report at http://www.marketdataforecast.com/market-reports/global-autoimmune-monoclonal-antibodies-1170/
Irregular functioning of humans’ immune system results in autoimmune disorders. Overproduction of self-reactive immune cells (such as antibodies & T-cells) damage regular functions of /cells/tissues/organs. This lead to different autoimmune disorders such as systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, and others diseases. Typically, drugs are used as a treatment to cure autoimmune disorders. The adverse effects associated with drugs has made switched to concentrate on monoclonal antibodies.
Monoclonal antibodies have the ability to offer less toxic and more efficient therapeutic alternatives to treat autoimmune diseases. Recent years have seen the emergence of monoclonal antibodies being used to treat wide array of diseases that are related to immune response. These antibodies are mono-specific comprising of identical immune cells which are clones of a single parent cell and are directed towards a specific cellular target. Thus monoclonal antibodies due to its customizable nature can be used to treat the self-reactive immune cells.
Get free sample report at http://www.marketdataforecast.com/market-reports/global-autoimmune-monoclonal-antibodies-1170/request-sample
Global Autoimmune Monoclonal Antibodies market is expected to witness growth owing to growing research & development to stimulate the development of monoclonal antibodies rising number of patients with autoimmune diseases, and increasing public & private organizations involvement to support advanced therapeutics development. In addition, rising demand for antibody based therapeutics, increasing adoption of advanced healthcare therapeutics, and growing number of lifestyle associated disorders are further promoting the growth of global autoimmune monoclonal antibodies.
Global market for Autoimmune Monoclonal Antibodies is segmented on the basis of source, application, end user and region.
1. On the basis of Source
•Murine
•Chimeric
•Humanized
•Human
2. On the basis of Application
•Systemic Lupus Erythematosus
•Rheumatoid Arthritis
•Multiple Sclerosis
•Transplant Rejection/Graft Versus Host Disease
•Others
3. On the basis of End User
•Hospitals/Clinics
•Research Institute
•Diagnostic Laboratories
4. On the basis of Geography
•North America
•Europe
•Asia-Pacific
•Latin America
•Middle-East & Africa
The key players in global Autoimmune Monoclonal Antibodies market include, GlaxoSmithKline plc (U.K.), AstraZeneca plc (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb (U.S.), Johnson & Johnson (U.S.), Innovent Biologics, Inc. (China), Takeda Pharmaceutical Company Ltd. (Japan), Amgen Inc. (U.S.), Biogen Inc.(U.S.), and UCB Company (Belgium).
About Market Data Forecast:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Contact:
Market Data Forecast, Inc.
+1-888-702-9626 (U.S. TOLL-FREE)
abhishek@marketdataforecast.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Market for Autoimmune Monoclonal Antibodies growing at a CAGR of 7.84% here
News-ID: 396261 • Views: …
More Releases from Market Data Forecast
Injection Molding Market Sees Explosive Growth Globally
According to the latest research report published by Market Data Forecast, the global injection molding market was worth USD 21.34 Billion in 2023. The global market is anticipated to grow at a CAGR of 5.94% from 2024 to 2029 and be worth USD 30.17 billion by 2029 from USD 22.61 billion in 2024.
Injection molding equipment includes mechanical machines that utilize injection molding procedures to obtain injection-molded plastic goods. Injection molding…
Analyzing the Pickles Market Worldwide
The global pickles market size is expected to be valued at USD 11.21 billion in 2024 and reach USD 12.86 billion by 2029, growing at a CAGR of 2.8% from 2024 to 2029.
Global Pickles Market Report Scope:
• Market Size (2029): USD 12.86 billion
• Market Size (2024): USD 11.21 billion
• CAGR (2024 to 2029): 2.8%
• Base Year: 2023
• Forecast Period: 2024 to 2029
• Segments Analysed: By Type, Distribution Channel, and Region
• Geographies Covered: North…
The Rise of Rice Flour And It's Gaining Popularity
The Rice Flour Market is expected to be worth USD 813.68 Billion in 2024 to achieve USD 1013.99 Billion in 2029 to grow at a CAGR of 4.5% from 2024 to 2029.
Global Rice Flour Market Report Scope:
• Market Size (2024): USD 813.68 Billion
• Market Size (2029): USD 1013.99 Billion
• CAGR (2024 to 2029): 4.5%
• Base Year: 2023
• Forecast Period: 2024 to 2029
• Segments Analysed: Product Type, Application, &…
Exploring the Growth Trajectory of the Pink Himalayan Salt Market
The Pink Himalayan Salt Market is expected to be worth USD 12.65 Billion in 2024 to achieve USD 15.62 Billion in 2029. grow at a CAGR of 4.3% from 2024 to 2029.
Global Pink Himalayan Salt Market Report Scope:
• Market Size (2024): USD 12.65 billion
• Market Size (2029): USD 15.62 billion
• CAGR (2024 to 2029): 4.3%
• Base Year: 2023
• Forecast Period: 2024 to 2029
• Segments Analysed: Type, Application, Distribution…
More Releases for Monoclonal
Impact COVID-19 on Monoclonal Antibodies Market 2021 Generated Opportunities for …
Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. For instance, in 2017,…
Monoclonal Antibodies Market Outline and Updates..!!
Rising adoption of strategies such as acquisition, collaboration, and license agreement by the market players is expected to bolster the monoclonal antibodies market growth over the forecast period. For instance, in 2018, F. Hoffman-La Roche AG and Kymab Group Ltd entered into a clinical trial agreement to evaluate KY1044 (product of Kymab Group), a human monoclonal antibody, for the treatment of solid tumors. Also, in 2018, Novartis AG entered into…
Global Monoclonal Antibody Diagnostic Reagents Market
Antibodies are an essential tool for many applications including flow cytometric analysis, immunoprecipitation, enzyme-linked immunosorbent assay (ELISA), immunocytochemistry, western blotting, and immunohistochemistry. Moreover, monoclonal antibodies (MAbs) are significant diagnostic reagent used in microbiological research, biomedical research, and also in diagnosis of various diseases such as HIV, hepatitis, herpes simplex, influenza infections, chlamydia, as well as for the treatment of cancer. Therefore, due to its importance in the clinical application, it…
Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | …
Complete Study of Monoclonal Antibody Custom Service Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa.
Avail Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4515
Monoclonal Antibody Custom Service Market – Overview
It is estimated that monoclonal antibody custom service market is expected to…
Global Monoclonal Antibodies Pipeline Analysis
The market for monoclonal antibodies (mAB) has become the fastest growing segment of the pharmaceutical industry. In 2012, there were more than 30 monoclonal antibody therapies approved by the FDA which generated annual sales of more than US$ 40 Billion. As the therapeutic mABs already play a significant part in effective medical treatment, it is most likely that their importance would increase by manyfolds in the future.
There has been a…
Global Cancer Monoclonal Antibodies Pipeline Analysis
In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selectively target cancer cells and extract various responses, thus indirectly protecting the non cancerous cells. This characteristic of monoclonal antibodies coupled with increasing potential of the oncology market has made many pharmaceutical giants to invest a significant portion of their R&D on cancer monoclonal antibodies.
In recent years the popularity…